enzymatic < enzyme < enzymes

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by enzyme

Number of relevant bibliographic references: 72.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000009 (2021)	Rashed Noor [Bangladesh]	Antiviral drugs against severe acute respiratory syndrome coronavirus 2 infection triggering the coronavirus disease-19 pandemic.
000088 (2021)	Minas Theodore Coroneo [Australie]	The eye as the discrete but defensible portal of coronavirus infection.
000181 (2021)	Pravindra Kumar [Inde] ; Ashok Kumar Sah [Inde] ; Greesham Tripathi [Inde] ; Anjali Kashyap [Inde] ; Avantika Tripathi [Inde] ; Rashmi Rao [Inde] ; Prabhu C. Mishra [Inde] ; Koustav Mallick [Inde] ; Amjad Husain [Inde] ; Manoj Kumar Kashyap [Inde]	Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19.
000263 (2021)	Fouzia Mesli [Algérie] ; Meriem Ghalem [Algérie] ; Ismail Daoud [Algérie] ; Said Ghalem [Algérie]	Potential inhibitors of angiotensin converting enzyme 2 receptor of COVID-19 by Corchorus olitorius Linn using docking, molecular dynamics, conceptual DFT investigation and pharmacophore mapping.
000277 (2021)	Gustavo José Da Silva Pereira [Brésil] ; Anderson Henrique França Figueredo Leão [Brésil] ; Adolfo Garcia Erustes [Brésil] ; Ingrid Beatriz De Melo Morais [Brésil] ; Talita Aparecida De Moraes Vrechi [Brésil] ; Lucas Dos Santos Zamarioli [Brésil] ; Cássia Arruda Souza Pereira [Brésil] ; Laís De Oliveira Marchioro [Brésil] ; Letícia Paulino Sperandio [Brésil] ; Ísis Valeska Freire Lins [Brésil] ; Mauro Piacentini [Italie] ; Gian Maria Fimia [Italie] ; Patrícia Reckziegel [Brésil] ; Soraya Soubhi Smaili [Brésil] ; Claudia Bincoletto [Brésil]	Pharmacological Modulators of Autophagy as a Potential Strategy for the Treatment of COVID-19.
000306 (2021)	Pobitra Borah [Inde] ; Pran Kishore Deb [Jordanie] ; Balakumar Chandrasekaran [Jordanie] ; Manoj Goyal [Arabie saoudite] ; Monika Bansal [Arabie saoudite] ; Snawar Hussain [Arabie saoudite] ; Pottathil Shinu [Arabie saoudite] ; Katharigatta N. Venugopala [Afrique du Sud] ; Nizar A. Al-Shar'I [Jordanie] ; Satyendra Deka [Inde] ; Vinayak Singh [Afrique du Sud]	Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted.
000333 (2021)	Arif Ali [Inde] ; Nasim Sepay [Inde] ; Mohd Afzal [Arabie saoudite] ; Nayim Sepay [Inde] ; Abdullah Alarifi [Arabie saoudite] ; M. Shahid [Inde] ; Musheer Ahmad [Inde]	Molecular designing, crystal structure determination and in silico screening of copper(II) complexes bearing 8-hydroxyquinoline derivatives as anti-COVID-19.
000346 (2021)	Hardeep Singh Tuli [Inde] ; Shivani Sood ; Jagjit Kaur [Australie] ; Pawan Kumar [Israël] ; Prachi Seth ; Sandeep Punia [Inde] ; Priya Yadav [Inde] ; Anil Kumar Sharma [Inde] ; Diwakar Aggarwal [Inde] ; Katrin Sak [Estonie]	Mechanistic insight into anti-COVID-19 drugs: recent trends and advancements.
000372 (2021)	Jyoti Choudhary [Inde] ; Shrivardhan Dheeman [Inde] ; Vipin Sharma [Inde] ; Prashant Katiyar [Inde] ; Santosh Kumar Karn [Inde] ; Manoj Kumar Sarangi [Inde] ; Ankit Kumar Chauhan [Inde] ; Gaurav Verma [Inde] ; Nitin Baliyan [Inde]	Insights of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) pandemic: a current review.
000473 (2021)	Jihad G. Youssef [États-Unis] ; Faisal Zahiruddin [États-Unis] ; George Youssef [États-Unis] ; Sriram Padmanabhan [États-Unis] ; Joe Ensor [États-Unis] ; Sai Ravi Pingali [États-Unis] ; Youli Zu [États-Unis] ; Sandeep Sahay [États-Unis] ; Swaminathan P. Iyer [États-Unis]	G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?
000510 (2021)	Smarajit Maiti [Inde] ; Amrita Banerjee [Inde]	Epigallocatechin gallate and theaflavin gallate interaction in SARS-CoV-2 spike-protein central channel with reference to the hydroxychloroquine interaction: Bioinformatics and molecular docking study.
000556 (2021)	Biswa Mohan Sahoo [Inde] ; B V V. Ravi Kumar [Inde] ; J. Sruti [Inde] ; Manoj Kumar Mahapatra [Inde] ; Bimal K. Banik [Arabie saoudite] ; Preetismita Borah [Inde]	Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection.
000567 (2021)	Jung-Soo Suh [Corée du Sud] ; Heon-Su Kim [Corée du Sud] ; Tae-Jin Kim [Corée du Sud]	Development of a SARS-CoV-2-derived receptor-binding domain-based ACE2 biosensor.
000571 (2021)	Mukesh Kumar [Inde] ; Jitender Madan [Inde] ; Rupinder Kaur Sodhi [Inde] ; Shashi Bala Singh [Inde] ; Anju Katyal [Inde]	Decoding the silent walk of COVID-19: Halting its spread using old bullets.
000605 (2021)	H R Abd El-Mageed [Égypte] ; Doaa A. Abdelrheem [Égypte] ; Shimaa A. Ahmed [Égypte] ; Aziz A. Rahman [Bangladesh] ; Khaled N M. Elsayed [Égypte] ; Sayed A. Ahmed [Égypte] ; Ashraf A. El-Bassuony [Égypte] ; Hussein S. Mohamed [Égypte]	Combination and tricombination therapy to destabilize the structural integrity of COVID-19 by some bioactive compounds with antiviral drugs: insights from molecular docking study.
000634 (2021)	Pauloc Greg Rio [Brésil] ; Regiane S. Da Cunha [Brésil] ; Gilson Biagini [Brésil] ; Bruna Bosquetti [Brésil] ; Júlia Budag [Brésil] ; Alberto Ortiz [Espagne] ; Maria Dolores Sánchez-Ni O [Espagne] ; Fellype C. Barreto [Brésil] ; Andréa E M. Stinghen [Brésil]	Chloroquine may induce endothelial injury through lysosomal dysfunction and oxidative stress.
000638 (2021)	Tariq A. Altalhi [Arabie saoudite] ; Khaled Alswat [Arabie saoudite] ; Walaa F. Alsanie [Arabie saoudite] ; Mohamed M. Ibrahim [Arabie saoudite, Égypte] ; Ali Aldalbahi [Arabie saoudite] ; Hamdy S. El-Sheshtawy [Égypte]	Chloroquine and hydroxychloroquine inhibitors for COVID-19 sialic acid cellular receptor: Structure, hirshfeld atomic charge analysis and solvent effect.
000645 (2021)	Riadh Badraoui [Arabie saoudite, Tunisie] ; Mohd Adnan [Arabie saoudite] ; Fevzi Bardakci [Arabie saoudite, Turquie] ; Mousa M. Alreshidi [Arabie saoudite]	Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism.
000652 (2021)	Jia Fu [République populaire de Chine] ; Qianqian Jia [République populaire de Chine] ; Huaxin Zhou [République populaire de Chine] ; Liyang Zhang [République populaire de Chine] ; Saisai Wang [République populaire de Chine] ; Peida Liang [République populaire de Chine] ; Yanni Lv [République populaire de Chine] ; Shengli Han [République populaire de Chine]	Cell membrane chromatography for the analysis of the interaction between chloroquine and hydroxychloroquine with ACE2 receptors.
000672 (2021)	Manasi P. Jogalekar [États-Unis] ; Anurag Veerabathini [États-Unis] ; Ankit B. Patel [États-Unis]	COVID-19: Antiviral agents and enzyme inhibitors/receptor blockers in development.
000758 (2021)	Lorenzo A. Cal [Italie] ; Matteo Rigato [Italie] ; Luca Sgarabotto [Italie] ; Lisa Gianesello [Italie] ; Giovanni Bertoldi [Italie] ; Verdiana Ravarotto [Italie] ; Paul A. Davis [États-Unis]	ACE2 and SARS-CoV-2 Infection Risk: Insights From Patients With Two Rare Genetic Tubulopathies, Gitelman's and Bartter's Syndromes.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "enzyme" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "enzyme" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    enzyme
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021